Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Stem Cell Donation

Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies

Summary:

Hematopoietic stem cell transplantation (HSCT) is the only curative option for patients with hemoglobinopathies. However, fewer than 30% of individuals will have an HLA-identical sibling. Improvement in outcomes after HSCT using unrelated donors (URD), and the development of novel nontoxic preparative regimens may make URD HSCT an option for hemoglobinopathy patients who do not have an HLA-identical sibling donor. The National Marrow Donor ProgramĀ® (NMDP) maintains a Registry of 4 million volunteer donors, and facilitates URD HSCT for patients with life-threatening blood diseases. In light of the increased representation of minorities in the NMDP registry, donor searches were run in April 2001 for a cohort of 272 thalassemia patients and 77 sickle cell disease (SCD) patients for whom searches had been submitted between 1989 and 2001 in order to determine the current likelihood of finding a potential donor of hematopoietic stem cells for hemoglobinopathy patients. About 59.7% SCD patients 80.2% thalassemia patients will find at least one potential 6/6 HLA matched donor or umbilical cord blood (UCB) unit. All patients will find at least one donor or UCB that is a potential 5/6 HLA match. In conclusion the majority of hemoglobinopathy patients will find at least one potential HLA matched unrelated bone marrow donor or UCB.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Walters MC, Storb R, Patience M et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000; 95: 1918ā€“1924.

    CASĀ  PubMedĀ  Google ScholarĀ 

  2. Lucarelli G, Galimberti M, Giardini C et al. Bone marrow transplantation in thalassemia. The experience of Pesaro. Ann NY Acad Sci 1998; 850: 270ā€“275.

    ArticleĀ  CASĀ  Google ScholarĀ 

  3. Walters MC, Patience M, Leisenring W et al. Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 1996; 2: 100ā€“104.

    CASĀ  Google ScholarĀ 

  4. Gaziev D, Galimberti M, Lucarelli G et al. Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants. Bone Marrow Transplant 2000; 25: 815ā€“821.

    ArticleĀ  CASĀ  Google ScholarĀ 

  5. La Nasa G, Giardini C, Argiolu F et al. Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes. Blood 2002; 99: 4350ā€“4356.

    ArticleĀ  CASĀ  Google ScholarĀ 

  6. Crespo Chozas D, Maldonado Regalado MS, Munoz Villa A . Unrelated donor bone marrow transplantation in a girl with thalassemia major. Med Clin (Barc) 2000; 114: 598ā€“599.

    ArticleĀ  CASĀ  Google ScholarĀ 

  7. Contu L, La Nasa G, Arras M et al. Successful unrelated bone marrow transplantation in beta-thalassaemia. Bone Marrow Transplant 1994; 13: 329ā€“331.

    CASĀ  PubMedĀ  Google ScholarĀ 

  8. Cheng CN, Lu CC, Sun HF et al. Successful matched-unrelated bone marrow transplantation in a patient with Beta-thalassemia major. J Pediatr Hematol Oncol 2002; 24: 579ā€“581.

    ArticleĀ  Google ScholarĀ 

  9. Golden F . The sickle-cell kid. An experimental transplant succeeds, giving a brave little boy the best Christmas present he can imagine. Time 1999; 154: 92.

    CASĀ  PubMedĀ  Google ScholarĀ 

  10. Sullivan KM, Anasetti C, Horowitz M et al. Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry. Ann NY Acad Sci 1998; 850: 312ā€“324.

    ArticleĀ  CASĀ  Google ScholarĀ 

  11. Maiers M, Flesch S . Unrelated Donor Hematopoetic Stem Cell Transplantation for Hemoglobinopathies Facilitated by NMDP. National Marrow Donor Program: Minneapolis; 2002.

    Google ScholarĀ 

  12. Krishnamurti L, Blazar BR, Wagner JE . Bone marrow transplantation without myeloablation for sickle cell disease. N Engl J Med 2001; 344: 68.

    ArticleĀ  CASĀ  Google ScholarĀ 

  13. Schleuning M, Stoetzer O, Waterhouse C et al. Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease. Exp Hematol 2002; 30: 7ā€“10.

    ArticleĀ  Google ScholarĀ 

  14. Chakraverty R, Peggs K, Chopra R et al. Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. Blood 2002; 99: 1071ā€“1078.

    ArticleĀ  CASĀ  Google ScholarĀ 

  15. Anasetti C, Petersdorf EW, Martin PJ et al. Improving availability and safety of unrelated donor transplants. Curr Opin Oncol 2000; 12: 121ā€“126.

    ArticleĀ  CASĀ  Google ScholarĀ 

  16. Gutoski M . Study verifies lack of ethnic diversity in bone marrow donors. Oncol Nurs Forum. 1995; 22: 717.

    CASĀ  PubMedĀ  Google ScholarĀ 

  17. Freytes CO, Beatty PG . Representation of Hispanics in the National Marrow Donor Program. Bone Marrow Transplant 1996; 17: 323ā€“327.

    CASĀ  PubMedĀ  Google ScholarĀ 

  18. Yancey AK, Coppo P, Kawanishi Y . Progress in availability of donors of color: the National Marrow Donor Program. Transplant Proc 1997; 29: 3760ā€“3765.

    ArticleĀ  CASĀ  Google ScholarĀ 

  19. Antin JH, Childs R, Filipovich AH et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 tandem meetings. Biol Blood Marrow Transplant 2001; 7: 473ā€“485.

    ArticleĀ  CASĀ  Google ScholarĀ 

  20. Davies SM, DeFor TE, McGlave PB et al. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors. Am J Med 2001; 110: 339ā€“346.

    ArticleĀ  CASĀ  Google ScholarĀ 

  21. Mentzer WC . Bone marrow transplantation for hemoglobinopathies. Curr Opin Hematol 2000; 7: 95ā€“100.

    ArticleĀ  CASĀ  Google ScholarĀ 

  22. Confer DL . The National Marrow Donor Program. Meeting the needs of the medically underserved. Cancer 2001; 91: 274ā€“278.

    ArticleĀ  CASĀ  Google ScholarĀ 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krishnamurti, L., Abel, S., Maiers, M. et al. Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies. Bone Marrow Transplant 31, 547ā€“550 (2003). https://doi.org/10.1038/sj.bmt.1703887

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703887

Keywords

This article is cited by

Search

Quick links